![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 30, 28364-28371, July 27, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Activation
Enhances Cell Survival*
§,
§,
, and
**
From the
Cell Stress and Aging Section, Laboratory of
Cellular and Molecular Biology, NIA, National Institutes of Health,
Baltimore, Maryland 21224-6825 and the ¶ Departments of
Biochemistry and Medicine, Vanderbilt University School of Medicine,
Nashville, Tennessee 37232-0146
Received for publication, March 26, 2001, and in revised form, May 7, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Phospholipase C- As a consequence of our aerobic environment, we are continually
exposed to reactive oxygen species. The deleterious and cumulative effects of oxidant injury to macromolecules appear to contribute to the
development of a wide variety of disease processes, including diabetes,
cancer, and Alzheimer's disease, and are believed to be a major factor
in aging (1). For these reasons our laboratory has long been interested
in the signaling pathways that mediate the effects of oxidative stress
on cellular physiology.
Oxidants activate many signaling pathways, and we and others have
demonstrated that growth factor receptors play an important role in
initiating cellular responses to oxidative stress (2-6). Following
exposure to H2O2, both the epidermal growth
factor receptor (EGFR)1 and
the platelet-derived growth factor receptor (PDGFR) are activated, leading to their dimerization and autophosphorylation. Furthermore, we
have demonstrated that certain proliferation-associated signaling pathways, including those leading to activation of extracellular signal-regulated kinase (ERK) and Akt, are activated by oxidative stress in a growth factor receptor-dependent manner and in
such instances promote cell survival (2). Thus, it appears that at
least some signaling pathways involved in regulating proliferation also
participate in the cellular response to oxidative stress.
Phospholipase C Several laboratories have demonstrated that PLC- Materials--
Hydrogen peroxide (H2O2)
was purchased from Sigma. Thapsigargin, Go6983, xestospongin C, TPA,
ionomycin, PP2, PP3, wortmannin, U73122, AG1478, compound 56, AG1296,
and N-acetylcysteine were all obtained from Calbiochem (San
Diego, CA). The JNK1 and PLC- Cell Culture, Treatment, and Survival Assays--
Establishment
of spontaneously immortalized wt MEF and Plcg1 null, derived
from targeting vector I (TV-I), has been described previously (16).
PLC-
For treatments with H2O2, an 8 M
stock solution was diluted to a working concentration in deionized
water and was added immediately to the culture medium (containing
serum). For cell survival assays, cells were plated in 60-mm dishes and
cultured overnight prior to treatment with H2O2
or other agents. Following treatment, cells were harvested and stained
with trypan blue, and live cells were counted using a hemocytometer.
The percentage of viable cells in the treatment groups was determined
from cell counts in treatment groups divided by cell counts of
untreated controls. Thus, a reduction in the number of viable cells in
treatment groups reflects cell death and/or inhibition of proliferation.
DAPI Staining--
DAPI staining was performed as described
previously (18). In brief, prior to staining, the cells were fixed with
4% paraformaldehyde for 30 min at room temperature and then washed
with phosphate-buffered saline. DAPI was added to the fixed cells for
1 h, after which they were examined by fluorescence microscopy.
Apoptotic cells were identified by condensation and fragmentation
of nuclei.
Immunoprecipitation and Immunoblot Analysis--
After
stimulation, cells were washed in ice-cold phosphate-buffered saline,
then harvested in 1 ml of lysis buffer (20 mM Hepes, pH
7.4, 2 mM EGTA, 50 mM JNK Kinase Assays--
JNK activity was measured by an
immunocomplex kinase assay as described previously (15). In brief, the
cells were lysed in 1 ml of lysis buffer (20 mM Hepes, pH
7.4, 2 mM EGTA, 50 mM Statistical Analysis--
An unpaired Student's t
test was used to assess statistical significance of differences between
normal MEF and Plcg1 null MEF. Differences were considered
significant for p values of 0.05 or less.
H2O2 Stimulates Tyrosine Phosphorylation of
PLC- Upstream Mediators of PLC-
Several studies have implicated PI3-K in the activation of PLC- Influence of PLC-
Examination of the kinetics of the response to 600 µM
H2O2 treatment revealed that the onset of death
occurred rapidly in Plcg1 null MEF (Fig. 4A).
Within 4 h, these cells began to shrink, round up, and detach from
the plate, and by 8 h less than 1% of the cells remained viable.
The wt MEF, on the other hand, remained attached to the plate, but took
on a more flattened, spread-out appearance. Thus, the growth inhibitory
effects of H2O2 were already apparent at early
time points. Plcg1 null MEF stained with DAPI displayed
features typical of apoptosis including condensation and fragmentation
of nuclei (Fig. 4B). In contrast, nuclei from H2O2-treated wt MEF remained homogeneously
stained with little evidence of fragmentation (Fig. 4B).
H2O2-induced Activation of
Mitogen-activated Protein Kinases (MAPK) and Akt Do Not Rely on
PLC- PLC-
PLC-
Taken together, the experiments described above argue strongly that
PLC- PLC- That PLC- A number of questions remain concerning the mechanisms leading to
PLC- It has been suggested that the increase in tyrosine
phosphorylation is due, at least in part, to inactivation of
phosphatases by H2O2, a mechanism that assumes
a certain basal level of tyrosine kinase activity in the absence of
overt stimulation. In support of this view,
H2O2 has been shown to reversibly inactivate
protein-tyrosine phosphatase 1B in cells and contribute to EGFR
phosphorylation in response to EGF treatment (37). Direct activation of
tyrosine kinases and inactivation of phosphatases by oxidants are not
mutually exclusive events. Rather, they are both likely to influence
phosphotyrosine levels and therefore the activities of upstream kinases
that ultimately regulate PLC- A major conclusion of our studies is that PLC- It is not clear how PLC-
1 (PLC-
1) is rapidly
activated in response to growth factor stimulation and plays an
important role in regulating cell proliferation and differentiation
through the generation of the second messengers diacylglycerol and
inositol 1,4,5-trisphosphate, leading to the activation of protein
kinase C (PKC) and increased levels of intracellular calcium,
respectively. Given the existing overlap between signaling pathways
that are activated in response to oxidant injury and those involved in
responding to proliferative stimuli, we investigated the role of
PLC-
1 during the cellular response to oxidative stress. Treatment of
normal mouse embryonic fibroblasts (MEF) with
H2O2 resulted in time- and
concentration-dependent tyrosine phosphorylation of
PLC-
1. Phosphorylation could be blocked by pharmacological
inhibitors of Src family tyrosine kinases or the epidermal growth
factor receptor tyrosine kinase, but not by inhibitors of the
platelet-derived growth factor receptor or phosphatidylinositol
3-kinase. To investigate the physiologic relevance of
H2O2-induced tyrosine phosphorylation of
PLC-
1, we compared survival of normal MEF and PLC-
1-deficient MEF
following exposure to H2O2. Treatment of
PLC-
1-deficient MEF with H2O2 resulted in
rapid cell death, whereas normal MEF were resistant to the stress.
Pretreatment of normal MEF with a selective pharmacological inhibitor
of PLC-
1, or inhibitors of inositol trisphosphate receptors and PKC,
increased their sensitivity to H2O2, whereas
treatment of PLC-
1-deficient MEF with agents capable of directly
activating PKC and enhancing calcium mobilization significantly
improved their survival. Finally, reconstitution of PLC-
1 protein
expression in PLC-
1-deficient MEF restored cell survival following
H2O2 treatment. These findings suggest an
important protective function for PLC-
1 activation during the
cellular response to oxidative stress.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1 (PLC-
1) is an enzyme that is recruited to the
membrane following activation of growth factor receptor tyrosine
kinases (7-10). As a result of its interaction with these signaling
molecules, PLC-
1 is activated by a mechanism that relies on tyrosine
phosphorylation. Activated PLC-
1 cleaves the membrane phospholipid
phosphatidylinositol 4,5-bisphosphate generating two second messengers,
diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). The former functions to activate protein kinase C
(PKC); the latter stimulates the release of Ca2+ from
internal stores. Through the pleiotropic actions of IP3 and
DAG, PLC-
1 participates in the regulation of cellular proliferation and differentiation (8).
1 undergoes tyrosine
phosphorylation in response to oxidant exposure, but the mechanisms
leading to this activation are not well understood (11-13). In
addition, the physiologic consequences of PLC-
1 activation by stress
are unclear. Based on our prior studies demonstrating the importance of
certain proliferation-associated signaling pathways in protecting the
cell against oxidative stress (2, 14, 15), we hypothesized that
PLC-
1 might also be important for transducing survival signals
resulting from oxidant exposure. To investigate this possibility, we
have employed normal mouse embryo fibroblasts (wt MEF), MEF that have
been rendered deficient for PLC-
1 by targeted disruption of both
plc-
1 alleles (Plcg1 null), and
Plcg1 null MEF in which PLC-
1 function has been
reconstituted through stable ectopic expression of PLC-
1
(Plcg1 null+). Our findings reported herein demonstrate that
H2O2 is a strong and specific activator of
PLC-
1, and further implicate PLC-
1 and its downstream effectors
in conferring protection against oxidative stress.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1 polyclonal antibodies were purchased
from Santa Cruz Biotechnology Inc. (Santa Cruz, CA). The
anti-phosphotyrosine monoclonal antibody (4G10) was from Upstate
Biotechnology, Inc. (Lake Placid, NY). The phospho-specific ERK rabbit
polyclonal antibody was from Promega (Madison, WI). The
phospho-specific p38 and phosphospecific Akt polyclonal antibodies were
purchased from New England Biolabs, Inc. (Beverly, MA).
1 was stably re-expressed in plcg1 null MEF using a
retroviral expression vector to produce plcg1 null+ MEF
(17). Although plcg1 null do not mobilize calcium in
response to growth factors, plcg1 null+ do. HeLa and T98G
cells were obtained from American Type Culture Collection (Manassas,
VA). All cell lines were grown in Dulbecco's modified Eagle's medium
(Biofluids, Rockville, MD) supplemented with 10% fetal bovine serum
(HyClone Laboratories, Inc., Logan, UT), 2 mM glutamine,
100 units/ml penicillin, and 100 µg/ml streptomycin, and were
maintained in 5% CO2.
-glycerophosphate, 1 mM Na3VO4, 5 mM NaF,
1% Triton X-100, 10% glycerol, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 5 µg/ml leupeptin, 5 µg/ml aprotinin). Equal amounts of protein were incubated with 5 µg of PLC-
1 antibody and 35 µl of 50% slurry of protein A-Sepharose for 4 h at 4 °C. Immune complexes were washed four times with the same lysis buffer and were resuspended in 2× sample buffer. For
immunoblot analysis, the precipitated proteins were resolved on 4-12%
NuPAGE BisTris gels (Novex, San Diego, CA) and transferred to
polyvinylidene difluoride membranes (Millipore, Bedford, MA). The
membranes were blocked with 10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.1% Tween 20, containing 5% milk, and
were then probed with different antibodies. Proteins were detected by
using enhanced chemiluminescence (ECL) reagents (Amersham Pharmacia
Biotech).
-glycerol phosphate,
1% Triton X-100, 10% glycerol, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 1 mM
Na3VO4, 5 mM NaF, 10 µg/ml
leupeptin, and 10 µg/ml aprotinin). Equal amounts of protein samples
were precipitated at 4 °C for 4 h with 5 µl of a JNK1 antibody with the addition of 35 µl of 50% slurry of protein
A-Sepharose (Amersham Pharmacia Biotech). The protein A-Sepharose beads
were washed three times each in lysis buffer and kinase assay buffer (20 mM MOPS, pH 7.2, 2 mM EGTA, 10 mM MgCl2, 1 mM dithiothreitol, and
0.1% Triton X-100). JNK kinase assays were performed using GST-c-Jun-(1-135) as a substrate. Samples were separated on a 12%
SDS-polyacrylamide gel and, after drying, were subjected to autoradiography.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1--
PLC-
1 is a tyrosine kinase substrate, and it is well
established that tyrosine phosphorylation of PLC-
1 is necessary for its activation (9, 10). To examine the effect of
H2O2 treatment on PLC-
1 phosphorylation, wt
MEF were exposed to various doses of the oxidant for 15 min and
tyrosine phosphorylation of PLC-
1 was examined by precipitating
PLC-
1 with a PLC-
1 antibody, followed by Western blotting
analysis with a phosphotyrosine-specific antibody. Western blot
analysis with a PLC-
1 antibody was used to verify that equal amounts
of PLC-
1 protein were present in the immunoprecipitates. As shown in
Fig. 1A,
H2O2 treatment resulted in PLC-
1 tyrosine phosphorylation in a dose- and time-dependent manner. A
significant increase in PLC-
1 phosphorylation was detected with
H2O2 concentrations as low as 200 µM and activation was rapid, occurring within 5 min of
treatment. Maximum levels of PLC-
1 phosphorylation were recorded
10-20 min after the addition of H2O2. It is
important to note that, in these experiments,
H2O2 was added directly to the serum-containing
culture medium, as opposed to cells being treated with
H2O2 while in phosphate-buffered saline. The
fact that such low doses of H2O2 increase
PLC-
1 tyrosine phosphorylation, despite the presence of
anti-oxidants in the supplemented medium, supports the physiologic
relevance of our observations. This response was not unique to MEF as
H2O2 treatment also led to phosphorylation of
PLC-
1 in two human cell lines, HeLa and T98G glioblastoma cells
(Fig. 1C). To confirm the involvement of reactive
oxygen species in PLC-
1 phosphorylation, the ability of
N-acetylcysteine (NAC), a scavenger of reactive oxygen
species and precursor of glutathione (19), to block phosphorylation was
assessed. As shown, NAC acted in a dose-dependent manner to
inhibit PLC-
1 phosphorylation in wt MEF (Fig.
1D).

View larger version (48K):
[in a new window]
Fig. 1.
H2O2 treatment
induces tyrosine phosphorylation of
PLC-
1. A, phosphorylation of
PLC-
1 by H2O2 is
concentration-dependent. wt MEF were exposed to the indicated
concentrations of H2O2 for 15 min. Cell lysates
were generated, and PLC-
1 was immunoprecipitated from ~500 µg of
lysate using a polyclonal PLC-
1 antibody. Western blotting was
employed to assess the tyrosine phosphorylation of PLC-
1 using a
phosphotyrosine-specific antibody (top panel). The same
membrane was then stripped and re-blotted with a PLC-
1 antibody to
demonstrate equal loading of protein in each lane (bottom
panel). B, phosphorylation of PLC-
1 by
H2O2 is rapid and sustained. wt MEF were
treated with 600 µM H2O2 for
indicated times, and PLC-
1 phosphorylation was assessed using
immunoprecipitation and Western blotting techniques as described above.
C, activation of PLC-
1 by H2O2 is
not specific to MEFs. HeLa and T98G cells were treated with
H2O2 for 15 min, and PLC-
1 phosphorylation
was assayed using immunoprecipitation and Western blotting techniques.
D, phosphorylation of PLC-
1 by
H2O2 is inhibited by the antioxidant NAC. Cells
were pretreated with NAC (1 mM or 2 mM) for 30 min prior to the addition of H2O2 (600 µM) to the culture medium. Cells were harvested 15 min
later for assessment of PLC-
1 phosphorylation. All experiments were
repeated three times, and data from one representative experiment are
shown.
1 Phosphorylation by
H2O2 Treatment--
We and others have
previously provided evidence that growth factor receptors, including
EGFR and PDGFR, play an important role in mediating the activation of
ERK and Akt in response to oxidant injury (2, 3, 5). Since PLC-
1 is
also strongly activated by growth factor stimulation of these
receptors, we investigated their involvement in mediating PLC-
1
activation following H2O2 treatment. As shown
in Fig. 2A, AG1478 and
compound 56, selective inhibitors of EGFR tyrosine kinase activity (20, 21), prevented PLC-
1 tyrosine phosphorylation in response to H2O2 treatment. In contrast, AG1296, a specific
inhibitor of PDGFR tyrosine kinase activity, had no effect on PLC-
1
phosphorylation, although these cells have been shown to express
functional PDGFRs (17). These findings suggest a role for EGFR, but not
PDGFR in mediating PLC-
1 phosphorylation by oxidative stress.
Previous studies have shown that Src family tyrosine kinases are
involved in signaling events stimulated by reactive oxygen species
(22-24) and Src kinase family members have also been demonstrated to
phosphorylate PLC-
1 and PLC-
2 in vitro (25, 26). To
address the role of Src family kinases in
H2O2-mediated phosphorylation of PLC-
1, we
utilized the selective Src family tyrosine kinase inhibitor PP2.
Phosphorylation of PLC-
1 by H2O2 was
completely blocked by the presence of 10 µM PP2. Similar
treatment with the same concentration of the inactive analog PP3 had no
effect on PLC-
1 phosphorylation by H2O2,
indicating that the effect of PP2 was selective.

View larger version (58K):
[in a new window]
Fig. 2.
Upstream mediators of
PLC-
1 phosphorylation by
H2O2 treatment. A, inhibition
of H2O2-induced PLC-
1 tyrosine
phosphorylation by pretreatment with EGFR inhibitors. Cells were
pretreated with various inhibitors or a solvent control for 30 min
prior to treatment with H2O2 (600 µM, 15 min). PLC-
1 phosphorylation was assayed by
Western blotting. B, wt MEF were pretreated with the
indicated doses of PP2 or its inactive analog PP3 for 30 min prior to
H2O2 (600 µM) treatment. Lysates
were prepared from cells 15 min after treatment with
H2O2 and were subjected to immunoprecipitation
(IP) with a PLC-
1 antibody. Precipitates were then
analyzed by immunoblotting (IB) using antibodies specific
for either phosphotyrosine or PLC-
1. C, inhibition of
PI3-K has no effect on tyrosine phosphorylation of PLC-
1 by
H2O2. wt MEF were treated with the PI3-K
inhibitor wortmannin (200 nM) for 30 min prior to treatment
with H2O2 (600 µM), and cell
lysates were prepared 15 min later. Phosphorylation of PLC-
1 was
assayed using immunoprecipitation and immunoblotting techniques, as
described above. All experiments were repeated three times, and data
from one representative experiment are shown.
1
(27-29), but others have not (30). As we have demonstrated previously
that the PI3-K/Akt signaling pathway is activated in response to
H2O2 treatment (2), we used the PI3-K inhibitor wortmannin to test the possibility that PI3-K is involved in mediating PLC-
1 phosphorylation in response to H2O2.
As shown in Fig. 2C, inhibition of PI3-K had no effect on
the tyrosine phosphorylation of PLC-
1 by
H2O2. Consistent with this, wortmannin does not
affect calcium mobilization in response to H2O2
(data not shown).
1 Status on Cell Survival following Oxidant
Challenge--
H2O2 acts in a
concentration-dependent manner to induce apoptosis in a
variety of cell types (15, 31-33), and a number of different signaling
pathways have been shown to be involved in controlling cellular
sensitivity to oxidant injury. To explore the role of PLC-
1 in
influencing cell survival following H2O2 treatment, we compared the sensitivity of wt MEF and Plcg1
null MEF to various concentrations of the oxidant. Trypan blue
exclusion was employed to assess viability 24 h after treatment.
As shown in Fig. 3, treatment with 300 µM H2O2 inhibited the growth of both wt and Plcg1 null MEF, resulting in a reduction in the
number of viable cells relative to untreated (control) cultures. At
higher concentrations (450-600 µM),
H2O2 became markedly cytotoxic for Plcg1 null MEF, with less than 1% of cells surviving
treatment with 600 µM H2O2.
However, little evidence of cytotoxicity was observed in wt MEF (Fig.
3, bottom panel; see also Fig.
4B and Fig. 7C).
This differential sensitivity of wt and Plcg1 null MEF to
H2O2 appears to be specific for oxidative
stress as wt and Plcg1 null MEF did not differ in their
susceptibility to another stressor, thapsigargin. Thapsigargin disrupts
calcium homeostasis by inhibiting calcium ATPases on the membrane of
the endoplasmic reticulum, which triggers a unique signaling cascade
referred to as the unfolded protein response (34). Depending on the
cell type, thapsigargin induces growth arrest and/or cell death.
Thapsigargin had the same effect on wt and Plcg1 null MEF;
although some growth arrest was observed, the treatment was toxic and
resulted in significant cell death in both cell lines (Fig. 3,
bottom panel). Consistent with the lack of a role
for PLC-
1 in influencing the responsiveness of MEF to thapsigargin
treatment, no PLC-
1 phosphorylation was evident in wt MEF following
treatment with the agent (Fig. 3, top panel).

View larger version (19K):
[in a new window]
Fig. 3.
PLC-
1 protects cells
from H2O2-induced death. Top
panel, wt MEF and Plcg1 null MEF were treated
with H2O2 (600 µM) and
thapsigargin (500 nM) and cell lysates were prepared 15 min
later. Western blotting techniques were then used to assess the
tyrosine phosphorylation status of PLC-
1. Bottom
panel, cells were treated with indicated doses of
H2O2 or thapsigargin for 24 h and
surviving cells (those able to exclude trypan blue) were counted. Data
are reported as percentage of survival relative to control (untreated)
cells. Black bars correspond to wt MEF, and
white bars correspond to Plcg1 null
MEF. Data are means of at least three independent experiments, and
error bars correspond to standard errors of the
mean. Asterisk (*) denotes significant differences in values
of wt MEF and Plcg1 null MEF determined using an unpaired
Student's t test.

View larger version (50K):
[in a new window]
Fig. 4.
H2O2 rapidly induces
death in Plcg1 null MEF. A, wt
MEF and Plcg1 null MEF were treated with 600 µM H2O2 for the indicated times,
and surviving cells (those able to exclude trypan blue) were counted.
Dramatic sensitivity of Plcg1 null MEF was observed as early
as 4 h after addition of H2O2 to culture
medium. Data are expressed as percentage of survival relative to
control (untreated) cells, and values are means of three or more
independent experiments. Error bars represent
standard errors of the mean. B, representative DAPI staining
of wt and Plcg1 null MEF, subjected to no treatment or
treated with 600 µM H2O2 for
8 h. Nuclei of apoptotic cells are fragmented and condensed.
1--
We have previously demonstrated that both the MAPK
(including ERK, JNK, and p38 members) and PI3-K/Akt signaling pathways are activated in response to H2O2 treatment and
influence cell survival (2, 15). To rule out the possibility that the
differential sensitivity of wt MEF and Plcg1 null MEF to
H2O2 might be attributed to effects of PLC-
1
on one or more of these pathways, we examined whether the PLC-
1
status affected activation of these kinases in response to oxidant
treatment. wt MEF and Plcg1 null MEF were harvested at
various times after exposure to 600 µM
H2O2, and examined for ERK, p38, and Akt
activation by Western blot analysis using phosphospecific ERK, p38, and
Akt antibodies. JNK activity was assessed by an immunocomplex kinase
assay using GST-c-Jun as a substrate. As shown in Fig.
5, no significant differences in the
levels of ERK, JNK, or Akt phosphorylation were noted between wt MEF
and Plcg1 null MEF. Although p38 activation was actually higher in the Plcg1 null MEF relative to wt MEF, neither
SB202190 nor SB203580 (pharmacologic inhibitors of p38) affected MEF
cell survival in response to H2O2 treatment
(data not shown). Thus, the influence of PLC-
1 on cell survival
appears to be independent of MAPK and PI3-K/Akt signaling pathways.

View larger version (53K):
[in a new window]
Fig. 5.
H2O2-induced
activation of MAPK and Akt does not rely on
PLC-
1. Cell lysates were prepared from wt
and Plcg1 null MEF treated with 600 µM
H2O2 for the indicated times. JNK1 activity was
determined by an immune complex kinase assay using GST-c-Jun-(1-135)
as substrate. Phosphorylation of ERK, p38, and Akt was assessed using
immunoblotting techniques with phospho-ERK, phospho-p38, and
phospho-Akt specific polyclonal antibodies. All assays were repeated
three times, and data from one representative experiment are
shown.
1 Function Is Required for Its Pro-survival Role in Response
to H2O2--
Our results thus far suggest that
PLC-
1 serves a pro-survival function during
H2O2 treatment. If so, then inhibition of
PLC-
1 activity would be expected to increase the sensitivity of wt
MEF cells to H2O2. To test this possibility, wt
MEF were treated with U73122, a selective inhibitor of
phosphoinositide-specific PLC
function, prior to challenge with
H2O2. As shown in Fig. 6A, 30 min of pretreatment
with 5 µM U73122 did significantly enhance the
sensitivity of wt MEF to H2O2 (Fig.
6A). U73122 treatment in the absence of
H2O2 had no effect on the cells (data not
shown). The inactive analog of U73122, known as U73433, could not be
included in these survival assays because it was toxic to both the wt
and Plcg1 null MEF.

View larger version (24K):
[in a new window]
Fig. 6.
Pharmacologic inhibition of
PLC-
1 increases susceptibility wt MEF to
H2O2-induced death. A, wt MEF
were pretreated with vehicle control or the PLC-
1 inhibitor U73122
(5 µM, 30 min) followed by H2O2
(600 µM, 24 h) and were compared with
Plcg1 null MEF treated with H2O2
(600 µM, 24 h). Cells were harvested and counted,
and survival was calculated relative to untreated cells. Survival of wt
MEF was significantly reduced as a result of U73122 pretreatment.
B, inhibitors of calcium release from the endoplasmic
reticulum and PKC activity increase susceptibility of wt MEF to
H2O2. wt MEF were treated with indicated doses
of H2O2 (24 h) following pretreatment with
vehicle control or a combination of XeC (1 µM) and Go6983
(5 µM). C, pharmacologic stimulation of
calcium release and PKC activity enhance survival of
H2O2-treated Plcg1 null
MEF. Plcg1 null MEF were treated with indicated doses of
H2O2 (24 h) in the absence or presence of
pretreatment with TPA (100 ng/ml, 30 min) and ionomycin (2 µM, 30 min). In all experiments cells were harvested,
stained with trypan blue, and counted. Percentage of survival is
reported as the number of viable cells relative to control groups. All
data are averages of at least three independent experiments and are
reported along with standard errors of the mean. Asterisk
(*) denotes significant difference in the value of wt MEF with and
without pretreatment with pharmacologic inhibitors of PLC-
1 or
Plcg1 null with and without pretreatment with pharmacologic
agents that mimic PLC-
1 function.
1 catalyzes hydrolysis of phosphatidylinositol 4,5-bisphosphate
to generate the second messenger molecules IP3 and DAG. The
former provokes a transient increase in intracellular free Ca (2+),
whereas the latter serves as a direct activator of PKC. It is through
these second messengers that PLC-
1 exerts its influence on
proliferation. To examine their importance in influencing cell survival
in response to oxidative stress, two complementary approaches were
employed. First, we pretreated wt MEF with a combination of XeC (an
IP3 receptor blocker) and Go6983 (a PKC inhibitor) to
abrogate the PLC-
1-mediated increases in intracellular
Ca2+ and PKC activity. Cell survival was assessed 24 h
later by trypan blue dye exclusion. As expected, the addition of XeC
and Go6983 partially reduced the survival of wt MEF following exposure
to H2O2 (Fig. 6B), although
treatment with XeC and Go6983 in the absence of
H2O2 had no effect on the cells (data not
shown). In the second approach, Plcg1 null MEF were treated
with pharmacologic agents that act downstream of PLC-
1 to increase
intracellular Ca2+ (ionomycin) and activate PKC (TPA).
Consistent with the hypothesis that these PLC-
1 effector functions
are important in promoting cell survival during oxidant injury, the
combination of ionomycin and TPA markedly improved survival of
H2O2-treated Plcg1 null MEF.
1 activation exerts a pro-survival influence during the cellular
response to oxidant injury. As a final test of this hypothesis, we
examined how reconstitution of PLC-
1 expression in Plcg1
null MEF would affect their response to H2O2
treatment. Plcg1 null cells with restored PLC-
1
expression (Plcg1 null+) were generated previously and have
been shown to exhibit normal PLC-
1 function in response to
proliferative signals (17, 30). As shown in Fig.
7A, the ectopically expressed
PLC-
1 in these cells undergoes tyrosine phosphorylation in response
to H2O2 treatment similar to that seen in wt
MEF. Next, we compared the sensitivity of wt MEF, Plcg1
null, and Plcg1 null+ MEF to various doses of H2O2. As depicted in Fig. 7B,
reconstitution of PLC-
1 expression in the Plcg1 null MEF
rescued them from H2O2-induced cytoxicity, resulting in cell viability essentially identical to that seen in wt
MEF. As seen in Fig. 7C, morphologic examination of
H2O2-treated wt MEF, Plcg1 null, and
Plcg1 null+ MEF confirmed the viability measurements
obtained by trypan blue dye exclusion in Fig. 7B, indicating
that PLC-
1 function is important in mediating resistance to harmful
effects of H2O2.

View larger version (52K):
[in a new window]
Fig. 7.
Restoration of PLC-
1
expression in Plcg1 null MEF protects against
H2O2. A, PLC-
1 protein is
phosphorylated by H2O2 in Plcg1
null+ MEF. Cells were treated with H2O2 (600 µM, 15 min), and PLC-
1 phosphorylation was assayed by
Western blot analysis. B, wt, Plcg1 null, and
Plcg1 null+ MEF were treated with the indicated doses of
H2O2 for 24 h, and surviving cells (those
able to exclude trypan blue) were counted. Percentage of survival is
reported relative to untreated controls. Data represent averages from
at least three independent experiments. Error
bars correspond to standard errors of the mean. Asterisk (*)
denotes significant difference in the value of Plcg1 null
compared with wt MEF. Differences between survival rates of
Plcg1 null+ and wt MEF are not statistically significant
(p > 0.5). C, representative phase contrast
micrographs of wt, Plcg1 null, and Plcg1 null+
MEF that were either left untreated or were treated with 600 µM H2O2 for 24 h. Nuclei of
apoptotic cells are fragmented and condensed.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1 is known to play an important role in regulating cell
proliferation through its interactions with both receptor and non-receptor tyrosine kinases. However, despite the existence of
significant overlap between proliferative and stress signaling pathways, a role for PLC-
1 in mediating cellular responses to stress
has not been appreciated. Here we have demonstrated that PLC-
1 is
tyrosine-phosphorylated in response to H2O2
treatment through Src family kinases and/or an
EGFR-dependent mechanism. In addition, using
Plcg1 null MEF and Plcg1 null MEF in which PLC-
1 function is restored, we have provided evidence that PLC-
1 expression supports cell survival following acute oxidant injury. Taken
together, these findings implicate PLC-
1 as an important regulatory
molecule in the cellular response to oxidative stress.
1 undergoes phosphorylation on tyrosine residues in
response to H2O2 treatment has been reported by
others (11-13). However, most of the previous studies have employed
high doses of H2O2 (in excess of 1 mM, and usually between 5 and 10 mM) and/or have required co-treatment with the phosphatase inhibitor pervanadate to observe phosphorylation. Such observations suggest that
H2O2 is, at best, a weak activator of PLC-
1.
In addition, the use of such high concentrations of
H2O2 raises questions concerning the biologic
relevance of the response, as they can be markedly cytotoxic for cells,
leading to rapid necrosis. Our current studies have employed much lower
concentrations of H2O2, and it is added to
cells in the presence of serum, which contains significant anti-oxidant
activity. We have demonstrated that, at concentrations as low as 200 µM, treatment with H2O2 results
in PLC-
1 phosphorylation, with concentration-dependent
increases occurring over a range of 200-1000 µM in MEF
(Fig. 1, A and B). Survival of MEF deficient in
PLC-
1 function is severely compromised over the same dose-response range of H2O2 (Fig. 3), which strongly supports
the biologic relevance of PLC-
1 phosphorylation and the role of
PLC-
1 in protecting cells against
H2O2-induced cell death.
1 phosphorylation in response to oxidant injury, although our
studies implicate both the EGFR and Src family kinases in the process.
Previously we proposed that oxidants might act to mimic the action of
EGF (and perhaps other growth factors) leading to elevated EGFR kinase
activity (2, 5). This in turn triggers the activation of other
signaling molecules including non-receptor type tyrosine kinases, such
as members of the Src family. Indeed, PLC-
1 phosphorylation occurs
rapidly in response to oxidant treatment, over the same time frame as
that seen for phosphorylation of EGFR by EGF and
H2O2 (2, 35). However, in response to certain stimuli, Src kinase activation has been found to lead to
phosphorylation of the EGFR (36). Therefore, it is certainly possible
that H2O2 acts in a similar fashion, first
activating Src kinases, followed by activation of the EGFR.
1 phosphorylation. However,
oxidant-mediated inactivation of a phosphatase involved in the
regulation of tyrosine phosphorylation on PLC-
1 is obviously not
sufficient to produce dramatic increase in tyrosine phosphorylation of
PLC-
1 that results from H2O2 treatment.
1 has a pro-survival
function in the cell's response to acute oxidative stress. Consistent
with our observations, overexpression of PLC-
1 in rat
pheochromocytoma PC12 cells was reported to inhibit apoptosis induced
by short wave length ultraviolet radiation (UVC) (38). UVC is believed
to exert its cellular affects, at least in part, through generation of
oxidative stress. However, a subsequent report showed no protective
influence of PLC-
1 overexpression against several different
treatments including H2O2 in NIH3T3 cells,
although PLC-
1 overexpression did favor survival (39). Interpretation of the significance of PLC-
1 expression levels in the
previous studies is complicated by the fact that PLC-
1 was
overexpressed in cells with otherwise normal PLC-
1 activity. Our
approach, which utilized MEF derived from embryos in which Plcg1 expression has been eliminated through targeted gene
disruption, avoided such complications and further allowed us the
opportunity to evaluate how restoration of PLC-
1 function in the
Plcg1 null fibroblasts affected their response to
H2O2. We observed that ectopic expression of
PLC-
1 in Plcg1 null MEF conferred resistance to
H2O2 equivalent to that seen in wt MEF (Fig. 7,
B and C). That PLC-
1 may have a similar role
in other stress circumstances is indicated by the finding that when
grown in suspension, Plcg1 null are more sensitive to death
than are Plcg1
null+.2
1 protects cells from oxidant injury.
PLC-
1 exhibits its influence on proliferation largely through the
generation of the second messengers inositol 1,4,5-triphosphate and
diacylglycerol, which in turn provoke the mobilization of Ca2+ and activate protein kinase C, respectively. That
these downstream events also contribute to PLC-
1's influence on
cell survival following H2O2 treatment was
evidenced by the finding that inhibitors of PKC and Ca2+
mobilization rendered wt MEF more sensitive to
H2O2 treatment, whereas pharmacologic
activation of PKC and Ca2+ mobilization in Plcg1
null MEF enhanced their survival. Importantly, the pharmacologic
agents were less effective modulators of survival in oxidant-treated
cells than was manipulation of Plcg1 expression. This may be
a reflection of the expected limitations of the pharmacologic approach
(due to, for example, the degree of inhibition or activation achieved
and the specificity of the agents actions). However, it could reflect
additional, unrecognized roles of PLC-
1. In this regard it is also
interesting to note that wt and Plcg1 null MEF do not differ
in their mitogenic response to EGF stimulation (40). The marked
differences in sensitivity to oxidant injury observed in wt MEF as
compared with Plcg1 null MEF may thus be attributable to a
unique function of PLC-
1 during stress. Attempts to identify
downstream targets of PLC-
1 activation that are involved in
mediating stress resistance are currently under way.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ These authors contributed equally to this work.
Supported by National Institutes of Health Grant CA75195.
** To whom all correspondence should be addressed: Laboratory of Cellular and Molecular Biology, Box 12, NIA, National Institutes of Health, 5600 Nathan Shock Dr., Baltimore, MD 21224. Tel.: 410-558-8446; Fax: 410-558-8386.
Published, JBC Papers in Press, May 11, 2001, DOI 10.1074/jbc.M102693200
2 A. Chattopahadhyay and G. Carpenter, submitted for publication.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: EGFR, epidermal growth factor receptor; MEF, mouse embryonic fibroblast; PLC, phospholipase C; NAC, N-acetylcysteine; PDGFR, platelet-derived growth factor receptor; XeC, xestospongin C; TPA, 12-O-tetradecanoyl phorbol-13-acetate; IP3, inositol 1,4,5-trisphosphate; DAG, diacylglycerol; PKC, protein kinase C; DAPI, 4,6-diamidino-2-phenylindole; MAPK, mitogen-activated protein kinase; JNK, c-Jun N-terminal kinase; ERK, extracellular signal-regulated kinase; PI3-K, phosphatidylinositol 3-kinase; GST, glutathione S-transferase; wt, wild type; EGF, epidermal growth factor; PP2, 4amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-D]pyrimidine; PP3, 4amino-7-phenylpyrazol[3,4-D]pyrimidine; MOPS, 4-morpholinepropanesulfonic acid; BisTris, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Finkel, T., and Holbrook, N. J. (2000) Nature 408, 239-247 |
| 2. | Wang, X., McCullough, K. D., Franke, T. F., and Holbrook, N. J. (2000) J. Biol. Chem. 275, 14624-14631 |
| 3. | Klotz, L. O., Schieke, S. M., Sies, H., and Holbrook, N. J. (2000) Biochem. J. 352, 219-225 |
| 4. | Rao, G. N. (1996) Oncogene 13, 713-719 |
| 5. | Chen, W., Martindale, J. L., Holbrook, N. J., and Liu, Y. (1998) Mol. Cell. Biol. 18, 5178-5188 |
| 6. | Zanella, C. L., Posada, J., Tritton, T. R., and Mossman, B. T. (1996) Cancer Res. 56, 5334-5338 |
| 7. | Kim, H. K., Kim, J. W., Zilberstein, A., Margolis, B., Kim, J. G., Schlessinger, J., and Rhee, S. G. (1991) Cell 65, 435-441 |
| 8. | Rhee, S. G., and Choi, K. D. (1992) J. Biol. Chem. 267, 12393-12396 |
| 9. | Rhee, S. G., and Bae, Y. S. (1997) J. Biol. Chem. 272, 15045-15048 |
| 10. | Carpenter, G., and Ji, Q. (1999) Exp. Cell Res. 253, 15-24 |
| 11. | Qin, S., Inazu, T., and Yamamura, H. (1995) Biochem. J. 308, 347-352 |
| 12. | Blake, R. A., Walker, T. R., and Watson, S. P. (1993) Biochem. J. 290, 471-475 |
| 13. | Schieven, G. L., Kirihara, J. M., Myers, D. E., Ledbetter, J. A., and Uckun, F. M. (1993) Blood 82, 1212-1220 |
| 14. | Guyton, K. Z., Liu, Y., Gorospe, M., Xu, Q., and Holbrook, N. J. (1996) J. Biol. Chem. 271, 4138-4142 |
| 15. | Wang, X., Martindale, J. L., Liu, Y., and Holbrook, N. J. (1998) Biochem. J. 333, 291-300 |
| 16. | Ji, Q. S., Winnier, G. E., Niswender, K. D., Horstman, D., Wisdom, R., Magnuson, M. A., and Carpenter, G. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 2999-3003 |
| 17. | Liao, H. J., Ji, Q. S., and Carpenter, G. (2001) J. Biol. Chem. 276, 8627-8630 |
| 18. | Wang, X., Gorospe, M., Huang, Y., and Holbrook, N. J. (1997) Oncogene 15, 2991-2997 |
| 19. | Cotgreave, I. A. (1997) Adv. Pharmacol. 38, 205-227 |
| 20. | Levitzki, A., and Gazit, A. (1995) Science 267, 1782-1788 |
| 21. | Bridges, A. J., Zhou, H., Cody, D. R., Rewcastle, G. W., McMichael, A., Showalter, H. D., Fry, D. W., Kraker, A. J., and Denny, W. A. (1996) J. Med. Chem. 39, 267-276 |
| 22. | Abe, J., Takahashi, M., Ishida, M., Lee, J. D., and Berk, B. C. (1997) J. Biol. Chem. 272, 20389-20394 |
| 23. | Aikawa, R., Komuro, I., Yamazaki, T., Zou, Y., Kudoh, S., Tanaka, M., Shiojima, I., Hiroi, Y., and Yazaki, Y. (1997) J. Clin. Invest. 100, 1813-1821 |
| 24. | Yoshizumi, M., Abe, J., Haendeler, J., Huang, Q., and Berk, B. C. (2000) J. Biol. Chem. 275, 11706-11712 |
| 25. | Liao, F., Shin, H. S., and Rhee, S. G. (1993) Biochem. Biophys. Res. Commun. 191, 1028-1033 |
| 26. | Khare, S., Bolt, M. J., Wali, R. K., Skarosi, S. F., Roy, H. K., Niedziela, S., Scaglione-Sewell, B., Aquino, B., Abraham, C., Sitrin, M. D., Brasitus, T. A., and Bissonnette, M. (1997) J. Clin. Invest. 99, 1831-1841 |
| 27. | Barker, S. A., Caldwell, K. K., Pfeiffer, J. R., and Wilson, B. S. (1998) Mol. Biol. Cell 9, 483-496 |
| 28. | Rameh, L. E., Rhee, S. G., Spokes, K., Kazlauskas, A., Cantley, L. C., and Cantley, L. G. (1998) J. Biol. Chem. 273, 23750-23757 |
| 29. | Falasca, M., Logan, S. K., Lehto, V. P., Baccante, G., Lemmon, M. A., and Schlessinger, J. (1998) EMBO J. 17, 414-422 |
| 30. | Ji, Q. S., Chattopadhyay, A., Vecchi, M., and Carpenter, G. (1999) Mol. Cell. Biol. 19, 4961-4970 |
| 31. | Kim, H., Lee, T. H., Park, E. S., Suh, J. M., Park, S. J., Chung, H. K., Kwon, O. Y., Kim, Y. K., Ro, H. K., and Shong, M. (2000) J. Biol. Chem. 275, 18266-18270 |
| 32. | Wagner, B. A., Buettner, G. R., Oberley, L. W., Darby, C. J., and Burns, C. P. (2000) J. Biol. Chem. 275, 22461-22469 |
| 33. | Sun, X., Majumder, P., Shioya, H., Wu, F., Kumar, S., Weichselbaum, R., Kharbanda, S., and Kufe, D. (2000) J. Biol. Chem. 275, 17237-17240 |
| 34. | Treiman, M., Caspersen, C., and Christensen, S. B. (1998) Trends Pharmacol. Sci. 19, 131-135 |
| 35. | Nishibe, S., Wahl, M. I., Hernandez-Sotomayor, S. M., Tonks, N. K., Rhee, S. G., and Carpenter, G. (1990) Science 250, 1253-1256 |
| 36. | Carpenter, G. (1999) J. Cell Biol. 146, 697-702 |
| 37. | Lee, S. R., Kwon, K. S., Kim, S. R., and Rhee, S. G. (1998) J. Biol. Chem. 273, 15366-15372 |
| 38. | Lee, Y. H., Kim, S., Kim, J., Young, K. K., Kim, M. J., Ryu, S. H., and Suh, P. (1999) Biochim. Biophys. Acta 1440, 235-243 |
| 39. | Lee, Y. H., Kim, S. Y., Kim, J. R., Yoh, K. T., Baek, S. H., Kim, M. J., Ryu, S. H., Suh, P. G., and Kim, J. H. (2000) Life Sci. 67, 827-837 |
| 40. | Ji, Q. S., Ermini, S., Baulida, J., Sun, F. L., and Carpenter, G. (1998) Mol. Biol. Cell 9, 749-757 |
This article has been cited by other articles:
![]() |
L. R. Klei and A. Barchowsky Positive Signaling Interactions between Arsenic and Ethanol for Angiogenic Gene Induction in Human Microvascular Endothelial Cells Toxicol. Sci., April 1, 2008; 102(2): 319 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sutton, V. Friand, S. Brule-Donneger, T. Chaigneau, M. Ziol, O. Sainte-Catherine, A. Poire, L. Saffar, M. Kraemer, J. Vassy, et al. Stromal Cell-Derived Factor-1/Chemokine (C-X-C Motif) Ligand 12 Stimulates Human Hepatoma Cell Growth, Migration, and Invasion Mol. Cancer Res., January 1, 2007; 5(1): 21 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Cai, J. C. He, L. Zhu, C. Lu, and H. Vlassara Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor PNAS, September 12, 2006; 103(37): 13801 - 13806. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mangat, T. Singal, N. S. Dhalla, and P. S. Tappia Inhibition of phospholipase C-{gamma}1 augments the decrease in cardiomyocyte viability by H2O2 Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H854 - H860. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Ali, P. T. Mungai, and P. T. Schumacker Stretch-induced phosphorylation of focal adhesion kinase in endothelial cells: role of mitochondrial oxidants Am J Physiol Lung Cell Mol Physiol, July 1, 2006; 291(1): L38 - L45. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Fasanaro, A. Magenta, G. Zaccagnini, L. Cicchillitti, S. Fucile, F. Eusebi, P. Biglioli, M. C. Capogrossi, and F. Martelli Cyclin D1 degradation enhances endothelial cell survival upon oxidative stress FASEB J, June 1, 2006; 20(8): 1242 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Hong, S. J. Moon, H. M. Byun, M. S. Kim, H. Jo, Y. S. Bae, S.-I. Lee, M. D. Bootman, H. L. Roderick, D. M. Shin, et al. Critical Role of Phospholipase C{gamma}1 in the Generation of H2O2-evoked [Ca2+]i Oscillations in Cultured Rat Cortical Astrocytes J. Biol. Chem., May 12, 2006; 281(19): 13057 - 13067. [Abstract] [Full Text] [PDF] |
||||
![]() |
|